Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002518363 | SCV000291842 | benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000987501 | SCV001136807 | benign | Interstitial lung disease 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001820778 | SCV002069720 | benign | not specified | 2021-08-11 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257604 | SCV002533099 | benign | Dyskeratosis congenita | 2020-03-26 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002321894 | SCV002605852 | benign | Dyskeratosis congenita; Hereditary cancer-predisposing syndrome | 2018-02-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001701883 | SCV004153874 | benign | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing | TERT: BS1, BS2 |
Genome Diagnostics Laboratory, |
RCV001701883 | SCV001927169 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001701883 | SCV001969345 | likely benign | not provided | no assertion criteria provided | clinical testing |